Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
VM26 therapy in children with drug-refractory lymphocytic leukemia
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'VM26 therapy in children with drug-refractory lymphocytic leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
High Risk
100%
Treatment Strategy
100%
Cytotoxic Activity
100%
Leukemia Cells
100%
Remission Induction
100%
Leukemia Patients
100%
Future Role
100%
Combination Chemotherapy
100%
Early Relapse
100%
Lymphocytic Leukemia
100%
Drug Refractory
100%
Pharmacology, Toxicology and Pharmaceutical Science
Leukemia
100%
Teniposide
100%
Lymphatic Leukemia
100%
Chemotherapy
50%
Remission
50%
Cytotoxicity
50%
Medicine and Dentistry
Teniposide
100%
Lymphoid Leukemia
100%
Leukemia
50%
Spontaneous Remission
50%
Leukemia Cell
50%
Cytotoxicity
50%
Combination Chemotherapy
50%